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From the nasopharynx to the pleural space, alterations in
fluid transport are central to a wide range of pathophysio-
logic processes in the respiratory tract. Despite intense in-
vestigation, details of the pathways for water transport in
the respiratory tract remain unclear. Insight into molecu-
lar mechanisms of membrane water permeability was pro-
vided by the discovery of the aquaporins, a growing family
of water-specific membrane channel proteins (1). In this
issue, Towne and colleagues (2) provide a rigorous descrip-
tion of changes in aquaporin expression in the respiratory
tract by using a murine model of pulmonary inflammation,
the adenovirus infection.
The existence of water-specific membrane channel pro-
teins was postulated by a small group of physiologists for
several decades, but the molecular identity of such proteins
remained enigmatic until recently. Aquaporin-1 (AQP1)
was serendipitously discovered during studies of erythro-
cyte membrane proteins (3). Several features suggested
that AQP1 could be the long-sought water channel, a sus-




oocytes. Transfer of AQP1-expressing oocytes from iso-
tonic to hypotonic medium resulted in rapid swelling and
rupture, whereas control oocytes changed little in volume
(4). Subsequent investigations in oocytes, as well as pro-
teoliposomes reconstituted with purified AQP1 protein,
demonstrated that the channel is specifically permeable to
water, but not to other small molecules, including protons,
ions, urea, and glycerol (4, 5). More recently, it has been





ever, the magnitude of this permeability may be much
lower than that of water, and the physiologic relevance is
debated.
Four aquaporins have been identified in the respiratory
tract: AQP1, AQP3, AQP4, and AQP5, each with a unique
distribution suggesting distinct physiologic roles (7, 8). AQP1
is expressed in the apical and basolateral membrane of the
microvascular endothelium (Figure 1A), as well as in the
visceral pleura. AQP3 is expressed in the basolateral mem-
brane of basal cells found in the tracheal and nasopharyn-
geal epithelium. AQP4 is present in the basolateral mem-
brane of ciliated columnar cells in bronchial, tracheal, and
nasopharyngeal epithelium. AQP5 is expressed in the api-
cal membrane of type I pneumocytes (Figure 1B), as well
as in the apical membrane of acinar cells in submucosal
glands of the airways and nasopharynx. The specificity of
AQP5 for type I pneumocytes has also been demonstrated
in studies of alveolar epithelial cell differentiation (9). The
ontogeny of each of the aquaporins in the lung is likewise
distinct. AQP1 is expressed from late gestation in rat lung
and is induced by corticosteroids in both fetal and adult
animals (7). AQP5 is expressed shortly after birth and is
not steroid responsive (10). Both AQP1 and AQP5 are ex-
pressed at high levels in adult animals. AQP4 expression





-agonists (11). The complex distribu-
tion and ontogeny of aquaporins in the respiratory tract
suggests potential involvement in a variety of pathophysi-
ologic processes.
The first examples of rate-limiting aquaporin expres-
sion were derived from studies of the kidney. AQP2 is the
vasopressin-responsive water channel that confers high
water permeability on the collecting duct (12). Deen and
colleagues (13) demonstrated that mutations in the AQP2
gene produce nephrogenic diabetes insipidus in humans.
This observation has now been expanded by the demon-
stration that acquired forms of nephrogenic diabetes insip-
idus, including lithium therapy, chronic hypokalemia, and
ureteral obstruction, all result from downregulation of
AQP2 expression (12). More recently, upregulation of
AQP2 has been shown in fluid retention states, including
congestive heart failure, pregnancy, and cirrhosis (1). The
physiologic relevance of AQP1 in the proximal tubule was
recently confirmed in AQP1-null mice, in which a pro-
found urinary concentrating defect became evident after
water deprivation (14). Another example of rate-limiting
aquaporin expression has recently been demonstrated in
the salivary gland, where AQP5 is expressed in the apical
membrane of acinar cells (8, 15). AQP5-null mice have a
marked reduction in saliva formation (16), and transfec-
tion of an aquaporin gene into radiation-damaged salivary
glands partially restores function (17).
Several lines of evidence suggest a physiologic role for
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ments (19) provided functional evidence of water chan-
nel–mediated transport across the alveolar membrane and
airway epithelium, respectively. More recently, studies in
AQP1-null mice demonstrated a 10-fold reduction in the
osmotic water permeability of the pulmonary vascular bed
compared with controls; a 2-fold reduction in permeability
was noted after increases in hydrostatic pressure (20). Al-
though each of these studies suggests a potential role for
aquaporins in regulating lung water permeability, the pre-
cise nature of that role in normal and pathologic condi-
tions remains unclear.
At first glance, aquaporins could provide the molecular
pathway for transcellular water movement across the en-
dothelial and epithelial barriers. Abundant expression of
AQP1 in both the apical and basolateral membrane of en-
dothelial cells in the microvasculature (Figure 1A) could
certainly facilitate transcellular water movement. How-
ever, the long-held model for water transport across the
pulmonary endothelium is one of predominantly paracel-
lular transport (21). How does one reconcile abundant ex-
pression of AQP1 with predictions of paracellular trans-
port? One possibility is that the paracellular transport
model is not correct, or at the least, is not operative in all
circumstances. Similar considerations led not only to re-
cent reassessment of water reabsorption in the renal prox-
imal tubule, but also the determination that transport is
predominantly transcellular rather than paracellular (22).
Other possibilities, however, certainly exist. For example,
do endothelial transport mechanisms differ between nor-
mal conditions and either injury or repair? Could paracel-
lular transport predominate in one set of circumstances,
while transcellular water transport predominate in an-
other? Alternatively, does AQP1 participate in cell vol-
ume regulation, and could AQP1-mediated changes in cell
volume contribute to dynamic regulation of the paracellu-
lar pathway? Much work is needed before we will be able
to define roles for AQP1 in the pulmonary vasculature.
Different but no less complex issues await evaluation of
AQP5 function in type I pneumocytes. Isolated type I cells
are highly water permeable (23). However, polarized ex-
pression of AQP5 in the apical membrane of type I pneu-
mocytes raises many questions. Are there undiscovered
aquaporins on the basolateral membrane, or could water-
transport across the basolateral membrane occur by non-
aquaporin-mediated mechanisms? In either case, does
AQP5 participate in transcellular water movement across
the type I epithelium? Perhaps the message of restricted
expression of AQP5 to the apical membrane is that trans-
cellular water movement does not occur across type I cells.
Since aquaporins are not active transporters, solute trans-
Figure 1. (A) Electron micrograph
of human capillary endothelial cell
from peribronchiolar vascular plexus.
Arrows point to 10-nm immunogold
particles labeling AQP1 on both
the apical and basolateral mem-
brane. BM, basement membrane;
N, nucleus; IC, interstitial cell. (B)
Electron micrograph of thin por-
tion of alveolar membrane from rat
showing type I pneumocyte (EPI)
and endothelial cell (ENDO). Ar-
rows point to 10-nm immunogold
particles labeling AQP5 on the api-
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porters must provide the driving force for water move-
ment. The presence of both sodium transporters and so-
dium channels in type II pneumocytes is well established
(24, 25). Although recent data suggest that type I pneu-
mocytes express these transport proteins as well (26, 27), it
remains to be determined whether their number or distri-
bution is sufficient to provide the necessary driving force
for transcellular water movement. Teleologically, there
might be some advantage to having water transport path-
ways at other sites in order to preserve the thin part of the
alveolar membrane. Rather than mediating transcellular
water movement, AQP5 expression may contribute to reg-
ulation of the composition and volume of the surface liq-
uid in the alveolus. Or, as suggested for AQP1, perhaps
AQP5 participates in cell volume regulation, helping to
maintain the attenuated state of the extended type I pneu-
mocyte cytoplasm. The discussions relating to aquaporin-
mediated gas permeability should also be considered.
Could AQP5 be permeated by gas molecules and contrib-
ute to epithelial gas exchange? Although this seems un-
likely at present, as with AQP1, many questions remain to
be answered before we will be able to clearly assign or
eliminate roles for AQP5 in the physiology of the alveolus.
Myriad transporters and mediators have been impli-
cated in the process of edema formation during inflamma-
tion. It is likely that no single factor will sufficiently ex-
plain either formation or resolution of edema in all
circumstances. In this context, however, the question of
what path the water follows still remains. Towne and col-
leagues have provided an interesting and important addi-
tion to the ongoing evaluation of aquaporin biology in the
respiratory tract (2). These investigators convincingly
demonstrate that in mice infected with adenovirus, expres-
sion of both AQP1 and AQP5 in the lung is markedly re-
duced, concurrent with an increase in lung wet-to-dry
weight ratios. The authors also observed that AQP1 and
AQP5 expression were reduced at sites distant from foci
of infection, consistent with the notion of humoral regula-
tion of AQP expression. These studies do not allow dis-
crimination of the specific role played by AQP1 or AQP5
in this process. They do, however, provide the first clear
example that inflammation in the lung can alter aquaporin
expression, an important observation that may prove rele-
vant to future consideration of a role for aquaporins in the
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